BMO Capital Markets Reiterates "$26.00" Price Target for Halozyme Therapeutics (HALO)
21 April 2015 - 5:24AM
Analyst Ratings Network
http://tickerreport.com/banking-finance/461925/bmo-capital-markets-reiterates-26-00-price-target-for-halozyme-therapeutics-halo/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN
Halozyme Therapeutics (NASDAQ:HALO)
Historical Stock Chart
From Apr 2024 to May 2024
Halozyme Therapeutics (NASDAQ:HALO)
Historical Stock Chart
From May 2023 to May 2024